Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years

Ilaria Muller(University of Milan), Marian Ludgate(Cardiff University), Mohd Shazli Draman(Nilai University), Peter Taylor(University Hospital of Wales), Samantha Loveless(University Hospital of Wales), Sara Butterworth(University Hospital of Wales), Neil P. Robertson(Cardiff University), Lei Zhang(Zhejiang University of Science and Technology), Mark Willis(Flinders University), Taha Nasser(University Hospital of Wales), Sarah Healy(University Hospital of Wales), Colin Dayan(University of Birmingham)
Thyroid
October 23, 2018
10.1089/thy.2018.0232
Cited by 33

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
|Nature Genetics|1996|647
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315